These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3039135)

  • 1. Synthesis and cardiotonic activity of a series of substituted 4-alkyl-2(1H)-quinazolinones.
    Bandurco VT; Schwender CF; Bell SC; Combs DW; Kanojia RM; Levine SD; Mulvey DM; Appollina MA; Reed MS; Malloy EA
    J Med Chem; 1987 Aug; 30(8):1421-6. PubMed ID: 3039135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives.
    Kanojia RM; Press JB; Lever OW; Williams L; McNally JJ; Tobia AJ; Falotico R; Moore JB
    J Med Chem; 1988 Jul; 31(7):1363-8. PubMed ID: 3385731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents.
    Hagedorn AA; Erhardt PW; Lumma WC; Wohl RA; Cantor E; Chou YL; Ingebretsen WR; Lampe JW; Pang D; Pease CA
    J Med Chem; 1987 Aug; 30(8):1342-7. PubMed ID: 3039132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents.
    Combs DW; Rampulla MS; Bell SC; Klaubert DH; Tobia AJ; Falotico R; Haertlein B; Lakas-Weiss C; Moore JB
    J Med Chem; 1990 Jan; 33(1):380-6. PubMed ID: 2153210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
    Davey D; Erhardt PW; Lumma WC; Wiggins J; Sullivan M; Pang D; Cantor E
    J Med Chem; 1987 Aug; 30(8):1337-42. PubMed ID: 3039131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones.
    Robertson DW; Krushinski JH; Pollock GD; Wilson H; Kauffman RF; Hayes JS
    J Med Chem; 1987 May; 30(5):824-9. PubMed ID: 3033241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS; Eardley D; Watkins R; Prioli N
    Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.
    Venuti MC; Stephenson RA; Alvarez R; Bruno JJ; Strosberg AM
    J Med Chem; 1988 Nov; 31(11):2136-45. PubMed ID: 2846839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cardiotonic activity of novel biimidazoles.
    Matthews DP; McCarthy JR; Whitten JP; Kastner PR; Barney CL; Marshall FN; Ertel MA; Burkhard T; Shea PJ; Kariya T
    J Med Chem; 1990 Jan; 33(1):317-27. PubMed ID: 2153209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore.
    Erhardt PW; Hagedorn AA; Davey D; Pease CA; Venepalli BR; Griffin CW; Gomez RP; Wiggins JR; Ingebretsen WR; Pang D
    J Med Chem; 1989 Jun; 32(6):1173-6. PubMed ID: 2542552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
    Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.
    Sircar I; Weishaar RE; Kobylarz D; Moos WH; Bristol JA
    J Med Chem; 1987 Nov; 30(11):1955-62. PubMed ID: 2822926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.
    Forest MC; Lahouratate P; Martin M; Nadler G; Quiniou MJ; Zimmermann RG
    J Med Chem; 1992 Jan; 35(1):163-72. PubMed ID: 1310113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
    Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
    Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).
    Venuti MC; Jones GH; Alvarez R; Bruno JJ
    J Med Chem; 1987 Feb; 30(2):303-18. PubMed ID: 3027339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors.
    Fossa P; Boggia R; Lo Presti E; Mosti L; Dorigo P; Floreani M
    Farmaco; 1997; 52(8-9):523-30. PubMed ID: 9507660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
    Endoh M; Satoh K; Yamashita S
    Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.